Foods that contain more than one type of molecule help us meet our daily requirement of nutrients. There is a limit to how much we can eat in a day, so if nutrient rich foods are consumed, we can easily provide the necessary building blocks for our bodies to maintain healthy function. This is not possible with foods that contain only one type of molecule.
This is a case of pulmonary embolism. In a patient treated for a broken leg, immobilization of the affected limb is strongly advised; although immobilization imposes a risk to develop deep vein thrombosis or the development of clot most commonly in the popliteal veins. This clot or thrombus can be dislodged and can travel to the right ventricle then pumped into the pulmonary circulation; causing dyspnea, chest pain, and hemoptysis.
Oxygen atom, liver, amino acid, fat molecule, then carbon dioxide molecule
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
